Business Wire

Mitigating Traffic Congestion and Accidents Using Dahua Smart Traffic Management Solution

13.12.2021 16:45:00 EET | Business Wire | Press release

Share

With rapid global urbanization and seemingly perpetual increase in vehicle ownership every year, improving traffic safety and efficiency has become a tough challenge. According to the assessment of international ITS organizations, an effective intelligent transportation system can help reduce traffic congestion and accidents by 20% and traffic delays by 25%. The Dahua Smart Traffic Management Solution, for example, has been applied in various countries to alleviate traffic problems and provide better driving and commuting experience. Equipped with AI, ANPR, image fusion, AR and robust communication technologies, the Dahua Smart Traffic Management Solution can accurately detect traffic violations and optimize signal control timing based on real-time data.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211213005357/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Graphic: Business Wire)

Traffic enforcement is one of the key focuses of this solution. By deploying traffic cameras with ANPR (e.g. ITC952-AU3F-LZF1640 model), traffic violations such as overspeeding, distracted driving, red light violation, unfastened seatbelt, illegal lane changing, etc. can be accurately detected. It supports recognition of number plates from 100 countries and allows algorithm integration with multiple countries. In addition, this Dahua solution also offers an AR Panoramic Platform that is connected to all frontend devices, and presents new labeling display system. It enables traffic operators to respond to traffic alerts and situations in time.

Another aspect of this solution involves signal control timing optimization based on real-time traffic flow. Powered by a lane-level traffic flow detection system, this solution can cover large scenes to detect multiple parameters such as lane flow, occupancy rate, queue length, traffic density, etc. With real-time data captured and analyzed, the traffic lights will automatically switch based on the time of the day and actual road traffic conditions, effectively mitigating urban traffic congestions. Green wave can be carried out during certain times for quick passage of vehicles. Also, these collected traffic data can help city operators in optimizing road network planning.

Meeting the numerous requirements of present-day traffic management, this solution has been applied in various countries and regions around the globe, including Serbia, Mongolia, Indonesia, and Saudi Arabia. One notable example of its effective implementation is in a country in Central Asia. It was deployed at an intersection where vehicle traffic reaches 170,000-250,000 cars per day. It significantly reduced waiting time, improved traffic efficiency by about 25%, helped enhance traffic flow, and lessened the effects of traffic congestion in the surrounding areas of the intersection.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Dahua PR
PR_Global@dahuatech.com

Zoe Xu (xu_shuyi@dahuatech.com)

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Azafaros Completes Enrollment of Phase 3 (NAVIGATE) Study Evaluating Nizubaglustat for the Treatment of Patients with GM1/GM2 Gangliosidoses23.7.2026 14:00:00 EEST | Press release

Azafaros, a private company building a portfolio of disease-modifying therapeuticsto become a leader in lysosomal storage disorders (LSDs) focused on addressing neurological symptoms, today announced the completion of patient recruitment in its Phase 3 study evaluating nizubaglustat for the treatment of GM1/GM2 gangliosidoses. “Completing enrollment in our Phase 3 GM1/GM2 study is a significant step toward potentially bringing nizubaglustat to patients and families living with these devastating neurodegenerative diseases," said Stefano Portolano, Chief Executive Officer at Azafaros. "We are deeply grateful to the patients, caregivers, investigators and advocacy groups who have made this milestone possible. As we advance the GM1/GM2 study toward data readout and regulatory submission, we continue to enroll in our Phase 3 NPC study and remain focused on our goal of addressing the significant unmet medical needs faced by these rare disease communities." Professor Roberto Giugliani, Princi

Francisco Partners Closes $21 Billion Across Flagship and Agility Funds23.7.2026 14:00:00 EEST | Press release

Francisco Partners (“FP”), a leading global investment firm that specializes in partnering with technology companies, today announced the closing of $21 billion in capital commitments across its Francisco Partners VIII, L.P. flagship fund and Francisco Partners Agility IV, L.P., its middle-market fund. FP exceeded its initial targets of $14.0 billion and $3.5 billion, respectively. This milestone builds on Francisco Partners' longstanding track record of performance, underscored by its distinction as the only firm to rank among the top three performers in each of the past six HEC-Dow Jones Large Buyout Performance Rankings.* “In our business, long-term success is created through a series of relationships built on years of trust and collaboration," said Dipanjan (“DJ”) Deb, Co-Founder and CEO of Francisco Partners. "We want to thank our investors for their support, our management teams for their dedication and performance, our friends and partners throughout the technology ecosystem, ou

Taiwanese ensembles showcase erhu and ocarina at Prague Folklore Days23.7.2026 11:21:00 EEST | Press release

The Prague Folklore Days 2026 was held on July 17 and 18 in the heart of Prague, bringing together 56 international arts groups from Germany, Austria, Slovakia, Spain, the Netherlands, and Poland. Four Taiwanese groups took part: Hildebrand Yu’s ocarina band, the Shi-xian Huqin Orchestra, the Taipei Folk Orchestra, and the Four Strings Ensemble. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722841530/en/ Taiwanese ensembles showcase erhu and ocarina at Prague Folklore Days Led by Huang Chun-sin, the official Taiwan representative band featured a diverse lineup of ocarina, erhu, and dance performers. Their program stood out among the European groups with its distinctive character and vivid stage presence. Hildebrand Yu’s ocarina band captivated audiences with warm, uplifting melodies accompanied by the ocarina and ukulele. Yu also performed “Twilight Waltz,” delivering a heartfelt piece of poetic expression, like sunlight

Taiwan Children’s Choirs Garner Major Awards at Hungarian Choral Competition23.7.2026 10:33:00 EEST | Press release

Competing against 36 leading contenders from 20 countries, four Taiwanese children’s choirs have garnered several major awards and top honors at the 5th Budapest International Choral Celebration, showcasing Taiwan’s cultural diversity and music excellence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722613876/en/ Puzangalan Children’s Choir and Yo Wu Wei Children’s Chorus join forces with international choral ensembles and orchestras to perform Mozart’s Requiem Mass in D minor, K. 626 at the Béla Bartók National Concert Hall of Müpa Budapest. With its pure, angelic voices and exceptional vocal techniques, Puzangalan Children’s Choir from Pingtung County won the top prize, Laurea Summa Cum Laude, in the Grand Prix Competition’s Youth Choir of Equal Voices, Folklore, and Sacred Music categories. In the Open Competition, Yo Wu Wei Children’s Chorus claimed three gold prizes in the categories of Youth Choir of Equal Voices

Evotec Selects Navan to Unify Global Travel, Payments, and Expense Management23.7.2026 10:00:00 EEST | Press release

Navan (NASDAQ: NAVN), the global AI-powered business travel and expense platform, today announced that Evotec (NASDAQ: EVO; Frankfurt Prime Standard: EVT), the global drug discovery and development company, has selected Navan to manage its complete corporate Travel and Expense (T&E) program in its top global markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722261092/en/ Global drug discovery leader partners with Navan to drive operational excellence and eliminate manual expense reporting A life science company that is pioneering the future of drug discovery and development, Evotec had historically managed T&E independently across different countries, meaning employees were dealing with a patchwork of different tools and manual offline processes. As part of its focus on operational excellence, Evotec is further streamlining these processes through one unified, easy-to-use platform that supports consistency, transpar

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye